Adaptimmune Therapeutics
ADAP
#9328
Rank
$66.39 M
Marketcap
$0.26
Share price
-20.31%
Change (1 day)
-81.02%
Change (1 year)

Adaptimmune Therapeutics (ADAP) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : $0.23 Billion USD

According to Adaptimmune Therapeutics's latest financial reports the company's total liabilities are $0.23 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Adaptimmune Therapeutics - Total liabilities on balance sheet (from 2014 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$0.24 B-1.59%
2022-12-31$0.24 B-6.28%
2021-12-31$0.26 B139.81%
2020-12-31$0.10 B89.82%
2019-12-31$57.9 M93.98%
2018-12-31$29.85 M-61.81%
2017-12-31$78.16 M14.32%
2016-12-31$68.37 M
2015-06-30$41.65 M-21.58%
2014-06-30$53.1 M1239.03%
2013-06-30$3.96 M-3.03%
2012-06-30$4.09 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$2.18 B 832.99%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.89 M-91.08%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.56 B 140.60%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$0.70 B 200.49%๐Ÿ‡บ๐Ÿ‡ธ USA